About Us

OrthoCyte is a wholly-owned subsidiary of BioTime, Inc. developing cellular therapies designed to reverse damage in the spine from injuries and aging. We have the largest diversity of pure musculo-skeletal progenitor stem cell lines and an enabling biomaterial delivery platform.